BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 28829370)

  • 1. MiR-30a-5p Inhibits Epithelial-to-Mesenchymal Transition and Upregulates Expression of Tight Junction Protein Claudin-5 in Human Upper Tract Urothelial Carcinoma Cells.
    Chung YH; Li SC; Kao YH; Luo HL; Cheng YT; Lin PR; Tai MH; Chiang PH
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28829370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-145 suppresses cell migration and invasion in upper tract urothelial carcinoma by targeting ARF6.
    Hsu WC; Li WM; Lee YC; Huang AM; Chang LL; Lin HH; Wu WJ; Li CC; Liang PI; Ke HL
    FASEB J; 2020 Apr; 34(4):5975-5992. PubMed ID: 32077148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53/miR-30a-5p/ SOX4 feedback loop mediates cellular proliferation, apoptosis, and migration of non-small-cell lung cancer.
    Quan X; Li X; Yin Z; Ren Y; Zhou B
    J Cell Physiol; 2019 Dec; 234(12):22884-22895. PubMed ID: 31124131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-26a-5p as a useful therapeutic target for upper tract urothelial carcinoma by regulating WNT5A/β-catenin signaling.
    Chung YH; Cheng YT; Kao YH; Tsai WC; Huang GK; Chen YT; Shen YC; Tai MH; Chiang PH
    Sci Rep; 2022 Apr; 12(1):6955. PubMed ID: 35484165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer.
    Chang CW; Yu JC; Hsieh YH; Yao CC; Chao JI; Chen PM; Hsieh HY; Hsiung CN; Chu HW; Shen CY; Cheng CW
    Oncotarget; 2016 Mar; 7(13):16462-78. PubMed ID: 26918943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of Low Expression of miR-30a-5p on Epithelial-Mesenchymal Transition and Metastasis in Ovarian Cancer.
    Wang L; Zhao S; Yu M
    DNA Cell Biol; 2019 Apr; 38(4):341-351. PubMed ID: 30839226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of miRNAs involved in angiogenesis, tumor cell proliferation, tumor suppressor inhibition, epithelial-mesenchymal transition and activation of metastasis in bladder cancer.
    Zaravinos A; Radojicic J; Lambrou GI; Volanis D; Delakas D; Stathopoulos EN; Spandidos DA
    J Urol; 2012 Aug; 188(2):615-23. PubMed ID: 22704449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-30a-5p Suppresses Tumor Metastasis of Human Colorectal Cancer by Targeting ITGB3.
    Wei W; Yang Y; Cai J; Cui K; Li RX; Wang H; Shang X; Wei D
    Cell Physiol Biochem; 2016; 39(3):1165-76. PubMed ID: 27576787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-30a-5p Inhibits Epithelial-to-Mesenchymal Transition by Targeting CDK6 in Nasal Polyps.
    Zhang T; Zhou Y; You B; You Y; Yan Y; Zhang J; Pei Y; Zhang W; Chen J
    Am J Rhinol Allergy; 2021 Mar; 35(2):152-163. PubMed ID: 32623901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-145-5p suppresses cell proliferation, migration, and invasion in upper tract urothelial carcinoma by targeting 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase.
    Luo HL; Lee YC; Chang YL; Hsu WC; Wu YT; Jhan JH; Lin HH; Wu YR; Ke HL; Liu HY
    J Cell Biochem; 2023 Sep; 124(9):1324-1345. PubMed ID: 37475541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetically-regulated miR-30a/c-5p directly target TWF1 and hamper ccRCC cell aggressiveness.
    Outeiro-Pinho G; Barros-Silva D; Moreira-Silva F; Lobo J; Carneiro I; Morais A; Martins EP; Gonçalves CS; Costa BM; Correia MP; Henrique R; Jerónimo C
    Transl Res; 2022 Nov; 249():110-127. PubMed ID: 35697274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deduction of Novel Genes Potentially Involved in Upper Tract Urothelial Carcinoma Using Next-Generation Sequencing and Bioinformatics Approaches.
    Lee HY; Chen YJ; Li CC; Li WM; Hsu YL; Yeh HC; Ke HL; Huang CN; Li CF; Wu WJ; Kuo PL
    Int J Med Sci; 2019; 16(1):93-105. PubMed ID: 30662333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.
    Cheng CW; Wang HW; Chang CW; Chu HW; Chen CY; Yu JC; Chao JI; Liu HF; Ding SL; Shen CY
    Breast Cancer Res Treat; 2012 Aug; 134(3):1081-93. PubMed ID: 22476851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2.
    Chen Z; Zhang J; Zhang Z; Feng Z; Wei J; Lu J; Fang Y; Liang Y; Cen J; Pan Y; Huang Y; Zhou F; Chen W; Luo J
    Cell Death Dis; 2017 Jun; 8(6):e2859. PubMed ID: 28569782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma.
    Wang W; Lin H; Zhou L; Zhu Q; Gao S; Xie H; Liu Z; Xu Z; Wei J; Huang X; Zheng S
    Eur J Surg Oncol; 2014 Nov; 40(11):1586-94. PubMed ID: 24290372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of microRNA expression pattern in upper tract urothelial carcinoma.
    Izquierdo L; Ingelmo-Torres M; Mallofré C; Lozano JJ; Verhasselt-Crinquette M; Leroy X; Colin P; Comperat E; Roupret M; Alcaraz A; Mengual L
    BJU Int; 2014 May; 113(5):813-21. PubMed ID: 24180461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer.
    Kumarswamy R; Mudduluru G; Ceppi P; Muppala S; Kozlowski M; Niklinski J; Papotti M; Allgayer H
    Int J Cancer; 2012 May; 130(9):2044-53. PubMed ID: 21633953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-30a-5p targets ITGA6 to inhibit oral squamous cell carcinoma progression.
    Zhang G; Wang H; Liu G; Huang J
    Pathol Res Pract; 2024 Jan; 253():155021. PubMed ID: 38103366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.